A bicyclic peptide scaffold was chemically adapted to generate diarylethene-based photoswitchable inhibitors of serine protease Bos taurus trypsin 1 (T1). Starting from a prototype molecule—sunflower trypsin inhibitor-1 (SFTI-1)—we obtained light-controllable inhibitors of T1 with Ki in the low nanomolar range, whose activity could be modulated over 20-fold by irradiation. The inhibitory potency as well as resistance to proteolytic degradation were systematically studied on a series of 17 SFTI-1 analogues. The hydrogen bond network that stabilizes the structure of inhibitors and possibly the enzyme–inhibitor binding dynamics were affected by isomerization of the photoswitch. The feasibility of manipulating enzyme activity in time and space ...
The introduction of a novel tetra-ortho-chloroazobenzene amino acid (CEBA) has enabled photoswitchin...
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimA series of peptidomimetic trifluoromethy...
We have developed novel polymeric photosensitizer prodrugs (PPPs) for improved photodynamic therapy....
OnlinePublThe ability to photochemically activate a drug, both when and where needed, requires optim...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
The work presented in this thesis examines the design, preparation and evaluation of light controlle...
This thesis presents the first example of reversible photoregulation of the binding of a protease, α...
Chemical probes that covalently interact with proteases have found increasing use for the study of p...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Chemical probes that covalently interact with proteases have found increasing use for the study of p...
Copyright © 2001 Elsevier Science Ltd. All rights reserved.The design, synthesis, photoisomerism and...
This thesis examines the design, synthesis and biological applications of a series of inhibitors whi...
The introduction of a novel tetra-ortho-chloroazobenzene amino acid (CEBA) has enabled photoswitchin...
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimA series of peptidomimetic trifluoromethy...
We have developed novel polymeric photosensitizer prodrugs (PPPs) for improved photodynamic therapy....
OnlinePublThe ability to photochemically activate a drug, both when and where needed, requires optim...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
The work presented in this thesis examines the design, preparation and evaluation of light controlle...
This thesis presents the first example of reversible photoregulation of the binding of a protease, α...
Chemical probes that covalently interact with proteases have found increasing use for the study of p...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Light regulation of drug molecules has gained growing interest in biochemical and pharmacological re...
Chemical probes that covalently interact with proteases have found increasing use for the study of p...
Copyright © 2001 Elsevier Science Ltd. All rights reserved.The design, synthesis, photoisomerism and...
This thesis examines the design, synthesis and biological applications of a series of inhibitors whi...
The introduction of a novel tetra-ortho-chloroazobenzene amino acid (CEBA) has enabled photoswitchin...
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimA series of peptidomimetic trifluoromethy...
We have developed novel polymeric photosensitizer prodrugs (PPPs) for improved photodynamic therapy....